Objectives Because risk stratification data represents a key domain of biomarker validation,
we compared associations between outcomes and various cardiovascular magnetic …

Background: Cardiac magnetic resonance techniques permit quantification of the
myocardial extracellular volume fraction (ECV), representing a surrogate marker of reactive …

Objectives: The aim of the present study was to evaluate whether extracellular volume
fraction (ECV) can reliably inform on the extent of diffuse fibrosis in the simultaneous …

Background Myocardial fibrosis (MF) in noninfarcted myocardium may be an interstitial
disease pathway that confers vulnerability to hospitalization for heart failure, death, or both …

Quantifying myocardial fibrosis (MF) with myocardial extracellular volume measures
acquired during cardiovascular magnetic resonance promises to transform clinical care by …

Purpose of review This review article discusses the evolution of extracellular volume (ECV)
quantification using both cardiovascular magnetic resonance (CMR) and computed …

Background Expansion of the myocardial extracellular volume (ECV) is a surrogate measure
of focal/diffuse fibrosis and is an independent marker of prognosis in chronic heart disease …

Objectives The aim of this study was to assess and delineate chronic myocardial infarction
(CMI) using precontrast and postcontrast T1 mapping techniques including quantification of …

Non-invasive quantification of the extracellular volume (ECV) is a method for the evaluation
of focal and diffuse myocardial fibrosis, potentially obviating the need for invasive …

Background—Extracellular matrix expansion may be a fundamental feature of adverse
myocardial remodeling, it appears to be treatable, and its measurement may improve risk …